Atorvastatin in Severity-Stratified Pulmonary Sarcoidosis: A Phase II Randomized Controlled Trial
Am J Respir Crit Care Med
.
2025 Mar;211(3):515-518.
doi: 10.1164/rccm.202403-0526RL.
Authors
Joseph R Fontana
1
,
Joel Moss
1
,
Dong-Yun Kim
2
,
Mario Stylianou
2
,
Stewart J Levine
1
,
Amisha V Barochia
1
,
Nargues Weir
1
,
Les R Folio
3
,
Huy Michael Do
4
,
Vincent Manganiello
1
Affiliations
1
Critical Care Medicine and Pulmonary Branch and.
2
Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
3
Moffitt Cancer Center, Tampa, Florida; and.
4
Dell Medical School, University of Texas at Austin, Austin, Texas.
PMID:
39701029
PMCID:
PMC11936144
(available on
2026-03-01
)
DOI:
10.1164/rccm.202403-0526RL
No abstract available
Publication types
Letter
Grants and funding
Division of Intramural Research at the National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, Maryland/United States